Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases

G Bjelakovic, D Nikolova, LL Gluud… - Cochrane database …, 2012 - cochranelibrary.com
Antioxidant supplements for prevention of mortality in healthy participants and patients with
various diseases - Bjelakovic, G - 2012 | Cochrane Library Skip to Content Cookies Our site …

Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life

AWS Rutjes, DA Denton, M Di Nisio… - Cochrane Database …, 2018 - cochranelibrary.com
Background Vitamins and minerals play multiple functions within the central nervous system
which may help to maintain brain health and optimal cognitive functioning. Supplementation …

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

Antithrombotic Trialists' Collaboration - Bmj, 2002 - bmj.com
Objective: To determine the effects of antiplatelet therapy among patients at high risk of
occlusive vascular events. Design: Collaborative meta-analyses (systematic overviews) …

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

Heart Protection Study Collaborative Group - The Lancet, 2002 - Elsevier
BACKGROUND: Throughout the usual LDL cholesterol range in Western populations, lower
blood concentrations are associated with lower cardiovascular disease risk. In such …

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial

Heart Protection Study Collaborative Group - The Lancet, 2003 - Elsevier
BACKGROUND: Individuals with diabetes are at increased risk of cardiovascular morbidity
and mortality, although typically their plasma concentrations of LDL cholesterol are similar to …

Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20 536 people with cerebrovascular disease or other high-risk conditions

Heart Protection Study Collaborative Group - The Lancet, 2004 - Elsevier
BACKGROUND: Lower blood cholesterol concentrations have consistently been found to be
strongly associated with lower risks of coronary disease but not with lower risks of stroke …

MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial

Heart Protection Study Collaborative Group - The Lancet, 2002 - Elsevier
BACKGROUND: It has been suggested that increased intake of various antioxidant vitamins
reduces the incidence rates of vascular disease, cancer, and other adverse outcomes …

C‐reactive protein and coronary heart disease: a critical review

JP Casas, T Shah, AD Hingorani… - Journal of internal …, 2008 - Wiley Online Library
Modestly elevated baseline concentrations of C‐reactive protein (CRP), the classical acute
phase protein, are associated with the long‐term risk of coronary heart disease in general …

Vitamin and mineral supplementation for preventing dementia or delaying cognitive decline in people with mild cognitive impairment

DA Denton, AWS Rutjes, LY Chong… - Cochrane Database …, 2018 - cochranelibrary.com
Background Vitamins and minerals have many functions in the nervous system which are
important for brain health. It has been suggested that various different vitamin and mineral …

Effects on 11-year mortality and morbidity of lowering LDL cholesterol with simvastatin for about 5 years in 20 536 high-risk individuals: a randomised controlled trial

Heart Protection Study Collaborative Group - The Lancet, 2011 - thelancet.com
Background Findings of large randomised trials have shown that lowering LDL cholesterol
with statins reduces vascular morbidity and mortality rapidly, but limited evidence exists …